Magnetic resonance spectroscopy of the fetal brain.
Fetal magnetic resonance spectroscopy (MRS) is technically feasible in utero and demonstrates similar findings to those observed in neonatal populations. MRS can provide additional information to conventional T1- and T2-weighted imaging of the fetal brain. It is of particular use when subtle changes are present on conventional fetal MRI sequences, and when imaging fetuses at risk of brain injury and metabolic abnormalities.
Pugash
Denise
D
Departments of Radiology and Obstetrics and Gynecology, University of British Columbia, BC Women's Hospital, Ultrasound 1T48,4500 Oak Street, Vancouver, Canada V6H 3N1. dpugash@cw.bc.ca
Krssak
Martin
M
Kulemann
Vanessa
V
Prayer
Daniela
D
D001921:Brain / Q000002:abnormalities / Q000196:embryology* / Q000378:metabolism; D001923:Brain Chemistry; D001927:Brain Diseases / Q000175:diagnosis; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000196:embryology; D005260:Female; D005317:Fetal Growth Retardation / Q000175:diagnosis; D006801:Humans; D020925:Hypoxia-Ischemia, Brain / Q000175:diagnosis; D007231:Infant, Newborn; D009682:Magnetic Resonance Spectroscopy; D008661:Metabolism, Inborn Errors / Q000175:diagnosis / Q000196:embryology; D011247:Pregnancy; D011296:Prenatal Diagnosis / Q000379:methods